Back
Bolt Biotherapeutics, Inc. 10K Form
Sell
45
BOLT
Bolt Biotherapeutics, Inc.
Last Price:
$5.31
Seasonality Move:
-11.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BOLT News And Ratings
See the #1 stock for the next 7 days that we like better than BOLT
BOLT Financial Statistics
Sales & Book Value
| Annual Sales: | $7.7M |
|---|---|
| Cash Flow: | $-9.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $16.72 |
| Price / Book: | 0.32 |
Profitability
| EPS (TTM): | -16.79910 |
|---|---|
| Net Income (TTM): | $-42.7M |
| Gross Margin: | $5.5M |
| Return on Equity: | -86.41% |
| Return on Assets: | -49.02% |
Bolt Biotherapeutics, Inc. Earnings Forecast
Key Bolt Biotherapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for BOLT is 71.64%.
-
The Selling, General & Administrative Expenses for BOLT have been equal to 240.01% of Gross Profit Margin.
-
The Research & Development expenses have been 718.96% of Revenue.
-
The Net Earning history of BOLT is -820.78% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 8 years.
Bolt Biotherapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BOLT |
| Website: | boltbio.com |
Debt
| Debt-to-Equity Ratio: | 0.73 |
|---|---|
| Current Ratio: | 3.57 |
| Quick Ratio: | 3.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BOLT Technical Analysis vs Fundamental Analysis
Sell
45
Bolt Biotherapeutics, Inc. (BOLT)
is a Sell
Is Bolt Biotherapeutics, Inc. a Buy or a Sell?
-
Bolt Biotherapeutics, Inc. stock is rated a SellThe current Bolt Biotherapeutics, Inc. [BOLT] share price is $5.42. The Score for BOLT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.